A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 503,094 shares of NTRA stock, worth $53.6 Million. This represents 43.28% of its overall portfolio holdings.

Number of Shares
503,094
Previous 397,436 26.58%
Holding current value
$53.6 Million
Previous $24.9 Million 84.82%
% of portfolio
43.28%
Previous 21.81%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $6.26 Million - $9.82 Million
105,658 Added 26.58%
503,094 $46 Million
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $15 Million - $25.1 Million
-400,000 Reduced 50.16%
397,436 $24.9 Million
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $3.65 Million - $5.25 Million
-84,000 Reduced 9.53%
797,436 $35.3 Million
Q4 2022

Feb 14, 2023

SELL
$34.17 - $47.91 $7.62 Million - $10.7 Million
-223,145 Reduced 20.2%
881,436 $35.4 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $6.46 Million - $9.92 Million
175,000 Added 18.83%
1,104,581 $48.4 Million
Q2 2022

Aug 15, 2022

SELL
$28.13 - $44.54 $5.58 Million - $8.84 Million
-198,400 Reduced 17.59%
929,581 $32.9 Million
Q1 2022

May 18, 2022

BUY
$30.32 - $91.33 $12.3 Million - $37.1 Million
405,800 Added 56.19%
1,127,981 $45.9 Million
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $14.6 Million - $20.1 Million
168,800 Added 30.5%
722,181 $67.4 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $9.56 Million - $12.1 Million
95,400 Added 20.83%
553,381 $61.7 Million
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $11.1 Million - $15.5 Million
129,145 Added 39.27%
457,981 $52 Million
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $4.03 Million - $5.48 Million
44,035 Added 15.46%
328,836 $33.4 Million
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $19 Million - $31.8 Million
284,801 New
284,801 $28.3 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Blue Water Life Science Advisors, LP Portfolio

Follow Blue Water Life Science Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Water Life Science Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Water Life Science Advisors, LP with notifications on news.